Feasibility of Using Bortezomib With or Without Chemotherapy in Patients With Atypical Teratoid/Rhabdoid Tumors

NCT06853080 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Atypical Teratoid/Rhabdoid Tumors (AT/RTs)
Central Nervous System (CNS) Tumors

Interventions

DRUG: Bortezomib

Sponsor

Taipei Medical University